Clinical Trial Update: Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial of triciribine phosphate monohydrate in adults with advanced hematologic malignancies (leukemia) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Triciribine Phosphate Monohydrate (triciribine phosphate monohydrate)

Snippet

Sponsor: Prescient Therapeutics, Ltd. | Conditions: Hematologic Malignancies, Leukemia | Phase 1 | Status: COMPLETED